HISTOCOMPATIBILITY PRODUCTS - HLA SEROLOGICAL : FLOW CYTOMETRY - ANTIBODY STUDY BY FLOW CYTOMETRY - ANVISA Registration 80391910011

Access comprehensive regulatory information for HISTOCOMPATIBILITY PRODUCTS - HLA SEROLOGICAL : FLOW CYTOMETRY - ANTIBODY STUDY BY FLOW CYTOMETRY in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80391910011 and manufactured by manufacturer not specified. The registration is held by PH 7 COMÉRCIO E REPRESENTAÇÕES DE PRODUTOS PARA DIAGNÓSTICOS LTDA with validity until Feb 11, 2029.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including IMMUCOR GTI DIAGNOSTICS, INC, ONE LAMBDA, INC., and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
2 Competitors
80391910011
2 Related Devices
Registration Details
ANVISA Registration Number: 80391910011
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

80391910011

25351656945201869

59920132000184

Dates and Status

Feb 11, 2019

11/02/2029

09/18/2025 19:00:01

Registration Details

80391910011

25351656945201869

59920132000184

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Feb 11, 2019

11/02/2029

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "HISTOCOMPATIBILITY PRODUCTS - HLA SEROLOGICAL : FLOW CYTOMETRY - ANTIBODY STUDY BY FLOW CYTOMETRY"